AI assistant
IXICO PLC — AGM Information 2019
Jan 18, 2019
7723_dva_2019-01-18_54256c8d-023c-4b91-a5d8-cc211f8f94d7.html
AGM Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4898N
IXICO plc
18 January 2019
18 January 2019
IXICO plc
("IXICO" or the "Company")
Results of AGM
IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed.
For further information please contact:
| IXICO plc Giulio Cerroni, Chief Executive Officer |
Tel: +44 20 3763 7499 |
| Shore Capital (Nomad and Broker) Edward Mansfield / Anita Ghanekar / Daniel Bush |
Tel: +44 20 7408 4090 |
| FTI Consulting Limited (Investor Relations) Simon Conway |
Tel: +44 20 3727 1000 |
About IXICO
IXICO is dedicated to delivering insights in neuroscience. Our mission is to transform the progression of our biopharmaceutical clients' neurological therapeutic pipelines through the application of novel medical imaging and mobile health digital technologies.
IXICO's data analytics services are used by the global biopharmaceutical industry to interpret data from brain scans and digital biosensors to enable better trial design, site qualification, patient selection and clinical outcomes. We provide technology-enabled services across all phases of clinical evaluation. Our integrated digital platform provides a scalable and secure infrastructure for the capture and analysis of regulatory compliant clinical data to enable clients to make rapid, better informed decisions. IXICO is also collaborating with partners to develop new analytical techniques and companion digital health products targeted at improving patient outcomes.
More information is available on www.IXICO.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
RAGCKFDDFBKKDDD